Patrick G Lepore's Net Worth

$15.2 Million

Estimate Recalculated Apr 10, 2025 08:46PM EST

Who is Patrick G Lepore

Patrick G Lepore has an estimated net worth of $15.2 Million. This is based on reported shares across multiple companies, which include PharMerica CORP, Innoviva, Inc., Matinas BioPharma Holdings, Inc., VYNE Therapeutics Inc., LANNETT CO INC, PAR PHARMACEUTICAL COMPANIES, INC., and Vyteris Holdings (Nevada), Inc..

SEC CIK

Patrick G Lepore's CIK is 0001055404

Past Insider Trading and Trends

2019 was Patrick G Lepore's most active year for acquiring shares with 8 total transactions. Patrick G Lepore's most active month to acquire stocks was the month of December. 2011 was Patrick G Lepore's most active year for disposing of shares, totalling 29 transactions. Patrick G Lepore's most active month to dispose stocks was the month of April. 2007 saw Patrick G Lepore paying a total of $2,400,000.00 for 233,800 shares, this is the most they've acquired in one year. In 2012 Patrick G Lepore cashed out on 630,678 shares for a total of $23,928,742.88, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PharMerica CORP

Investor
Updated Dec 08, 2017
Form 4
-100.00%
-29.57K
$29.25
-$864.92K
Dec 08, 2017
Disposition
Dec 07
Form 4
19.46%
4.82K
Jun 16, 2017
29.57K
Grant
Jun 14
Form 4
26.38%
5.17K
Jun 21, 2016
24.75K
Grant
Jun 17
Form 4
23.52%
3.73K
Jun 23, 2015
19.59K
Grant
Jun 19
Form 4
37.21%
4.30K
Jun 18, 2014
15.86K
Grant
Jun 17
Form 4/A
92.60%
5.56K
Jul 03, 2013
11.56K
Grant
Jun 18
Form 4
94.75%
5.68K
Jun 19, 2013
11.69K
Grant
Jun 17
Form 4
6.00K
Jan 14, 2013
6.00K
Grant
Jan 14
Form 3
Jan 14, 2013
Showing 9 results

Innoviva, Inc.

Investor
Updated Apr 24, 2017
Form 4
51.68%
19.86K
Apr 24, 2017
58.28K
Grant
Apr 20
Form 4
38.42K
Oct 27, 2016
38.42K
Grant
Oct 26
Form 3
Oct 27, 2016
Showing 3 results

Matinas BioPharma Holdings, Inc.

Investor
Updated Nov 10, 2020
Form 4
122.61K
Nov 10, 2020
122.61K
Grant
Nov 02
Form 4
33.33%
100.00K
$0.73
$73.05K
May 18, 2020
400.00K
Purchase
May 14
Form 4
50.00%
100.00K
$1.06
$105.53K
Nov 19, 2019
300.00K
Purchase
Nov 15
Form 4
107.42K
Nov 05, 2019
107.42K
Grant
Nov 01
Form 4
100.00%
100.00K
$0.72
$71.85K
Aug 20, 2019
200.00K
Purchase
Aug 16
Form 4
100.00K
$0.95
$95.25K
May 20, 2019
100.00K
Purchase
May 16
Form 4
128.30K
Nov 05, 2018
128.30K
Grant
Nov 01
Form 4
150.00K
Sep 06, 2018
150.00K
Grant
Sep 05
Form 3
Sep 06, 2018
Showing 9 results

VYNE Therapeutics Inc.

Investor
Updated Jan 03, 2024
Form 4
20.00K
Jan 03, 2024
20.00K
Grant
Jan 01
Form 4
20.00K
Dec 15, 2023
20.00K
Grant
Dec 13
Form 4
55.39%
13.00K
$3.91
$50.78K
Nov 17, 2023
36.47K
Purchase
Nov 15
Form 4
576.04%
20.00K
$2.48
$49.68K
Mar 22, 2023
23.47K
Purchase
Mar 20
Form 4
20.50K
Aug 12, 2022
20.50K
Grant
Aug 10
Form 3
Sep 14, 2020
Showing 6 results

LANNETT CO INC

Investor
Updated Nov 14, 2022
Form 4
20.53%
100.00K
$0.49
$49.00K
Nov 14, 2022
587.15K
Purchase
Nov 10
Form 4
11.44%
50.00K
$0.54
$27.00K
May 17, 2022
487.15K
Purchase
May 16
Form 4
12.92%
50.00K
$0.88
$44.00K
Feb 10, 2022
437.15K
Purchase
Feb 08
Form 4
14.83%
50.00K
$1.71
$85.50K
Nov 30, 2021
387.15K
Purchase
Nov 29
Form 4
6.31%
20.00K
$3.31
$66.20K
Sep 09, 2021
337.15K
Purchase
Sep 08
Form 4
21.83%
56.82K
Sep 02, 2021
317.15K
Grant
Aug 31
Form 4
8.32%
20.00K
$4.18
$83.60K
May 12, 2021
260.33K
Purchase
May 11
Form 4
19.36%
38.99K
Sep 03, 2020
240.33K
Grant
Sep 01
Form 4
14.18%
25.00K
$9.82
$245.50K
Sep 05, 2019
201.34K
Purchase
Sep 03
Form 4
23.41%
33.45K
Jul 22, 2019
176.34K
Grant
Jul 19
Form 4
21.21%
25.00K
$7.32
$183.00K
May 09, 2019
142.90K
Purchase
May 08
Form 4
26.91%
25.00K
$8.93
$223.25K
Feb 13, 2019
117.90K
Purchase
Feb 12
Form 4
36.82%
25.00K
$5.10
$127.50K
Dec 17, 2018
92.90K
Purchase
Dec 13
Form 4
58.28%
25.00K
$5.34
$133.50K
Sep 04, 2018
67.90K
Purchase
Aug 31
Form 4
60.66%
16.20K
Jul 23, 2018
42.90K
Grant
Jul 20
Form 4
1,470.59%
25.00K
$15.13
$378.25K
May 14, 2018
26.70K
Purchase
May 11
Form 3
Jul 05, 2017
1.70K
Showing 17 results

PAR PHARMACEUTICAL COMPANIES, INC.

Executive Chairman
Updated Oct 02, 2012
Form 4
-100.00%
-658.72K
$42.10
-$25.49M
Oct 02, 2012
Disposition
Sep 28
Form 4
-0.85%
-1.65K
$35.65
-$58.89K
Jan 13, 2012
229.79K
Tax
Jan 11
Form 4
-2.70%
-5.37K
$35.09
-$188.26K
Jan 11, 2012
231.45K
Tax
Jan 09
Form 4
-1.46%
-2.94K
$32.17
-$94.61K
Jan 06, 2012
236.81K
Tax
Jan 04
Form 4
53.33%
8.00K
$25.92
$207.36K
Sep 07, 2011
292.88K
Purchase
Sep 06
Form 4
-3.30%
-8.69K
$29.09
-$252.79K
Aug 10, 2011
284.88K
Tax
Aug 09
Form 4
-6.73%
-65.47K
$23.64
-$1.38M
May 11, 2011
937.56K
Sale
May 09
Form 4
-0.92%
-2.46K
$29.00
-$71.19K
Mar 24, 2011
293.57K
Tax
Mar 22
Form 4/A
8.84%
43.65K
$36.00
-$251.35K
Jan 31, 2011
567.63K
Grant
Jan 06 - Jan 10
Form 4
0.08%
208.00
$35.98
-$964.12K
Jan 13, 2011
294.27K
Grant
Jan 11
Form 4
-1.99%
-5.37K
$36.00
-$193.14K
Jan 12, 2011
294.06K
Tax
Jan 10
Form 4
22.89%
50.49K
Jan 10, 2011
301.04K
Grant
Jan 06
Form 4
-1.32%
-2.94K
$39.79
-$116.98K
Jan 06, 2011
250.55K
Tax
Jan 04
Form 4
-1.29%
-2.93K
$32.93
-$96.39K
Nov 02, 2010
253.49K
Tax
Nov 01
Form 4
-2.87%
-6.69K
$28.51
-$190.73K
Aug 10, 2010
256.42K
Tax
Aug 09
Form 4
-0.80%
-1.89K
$25.09
-$47.42K
Mar 24, 2010
263.11K
Tax
Mar 22
Form 4
-2.25%
-5.40K
$25.86
-$139.70K
Jan 12, 2010
251.50K
Tax
Jan 08 - Jan 11
Form 4
38.06%
81.20K
Jan 06, 2010
324.53K
Grant
Jan 04
Form 4
-1.35%
-2.93K
$20.97
-$61.38K
Nov 02, 2009
243.34K
Tax
Oct 30
Form 4
-3.00%
-6.69K
$15.95
-$106.71K
Aug 12, 2009
246.26K
Tax
Aug 10
Form 4
-0.84%
-1.89K
$11.19
-$21.15K
Mar 24, 2009
252.32K
Tax
Mar 23
Form 4
-0.56%
-1.27K
$12.59
-$16.01K
Jan 14, 2009
254.22K
Tax
Jan 12
Form 4
102.40%
180.32K
Jan 12, 2009
386.42K
Grant
Jan 08
Form 4
-1.63%
-2.93K
$9.50
-$27.81K
Oct 31, 2008
206.10K
Tax
Oct 30
Form 4
2.87%
5.00K
$10.58
$52.90K
Oct 20, 2008
209.03K
Purchase
Oct 17
Form 4
-3.70%
-6.69K
$15.23
-$101.89K
Aug 12, 2008
204.03K
Tax
Aug 11
Form 4
1.06%
1.89K
$18.37
$34.72K
Mar 26, 2008
210.72K
Tax
Mar 24
Form 4
33.73%
46.06K
Jan 15, 2008
212.61K
Grant
Jan 11
Form 4
30.00K
$18.36
$550.80K
Oct 04, 2007
30.00K
Purchase
Oct 03
Form 4
347.22%
200.00K
$20.00
$2.40M
Sep 12, 2007
257.60K
Grant
Aug 09
Form 4
96.57%
33.80K
Mar 26, 2007
68.80K
Grant
Mar 22
Form 4
155.00K
Nov 01, 2006
162.50K
Grant
Oct 30
Form 3/A
Jun 20, 2006
2.50K
Form 3
May 30, 2006
2.50K
Showing 34 results

Vyteris Holdings (Nevada), Inc.

Investor
Updated May 03, 2005
Form 3
May 03, 2005
Showing 1 results